CellPoint Digital Launches One Source Orchestration, the First Payment Optimization Platform to Meet the Demand of OOSD Retailing Models
Built for the new generation of airline and travel retail, OSO turns…
New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-‘749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed
Through Week 56 in the SOLARIS trial, there were no suspected or…
C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting
September 20, 2025 11:00 ET Â | Source: C4 Therapeutics, Inc. Cemsidomide in…
Growing in Southeast Asia: Messe Frankfurt partners with GIAMM on Automechanika Jakarta debuting in 2026
Jakarta, 17 September 2025. During today’s press conference, Messe Frankfurt announced the…
Rezolve Ai Gains Powerful Institutional Backing as Market Undervaluation Becomes Clear
Citadel, BlackRock, Vanguard, Jane Street, Northern Trust, Man Group, and State Street…
New Bounteous White Paper Maps the AI Whitespace for Business Leaders
Study of 300+ executives identifies misalignment between marketing and IT as key…
Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder
Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by…
Praxis Medicines to Present at 36th International Epilepsy Congress 2025 in Lisbon, Showcasing Latest RADIANT Study Data and Leading Precision Epilepsy Pipeline
BOSTON, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ:…
MLK Listed on Binance Alpha, Spotlighting Its Global Loyalty Platform Potential
- MLK listed on Binance Alpha on August 16, highlighting service reliability…